DIA's Impact on the Clinical Research Industry
In the fifth and final part of this video interview, Carie Pierce, SVP, global head of growth & business development, DIA touches on how the organization continues to break down silos in clinical research and provide a medium for collaboration.
ACT: What kind of impact do you hope DIA and its conferences have within the clinical trials industry?
Pierce: DIA really strives to be a connector that brings the right stakeholders together to have conversations that aren't going to happen elsewhere or things. There are so many things that happen in a silo in this industry. We believe strongly that it's only through cooperation and collaboration, learning from mistakes of others, tapping into their successes and building on top of them. We believe that that's the only way this industry is going to continue to really accelerate at the rate that patients need it to accelerate, and we have to be willing to have those conversations. I think DIA is the hub for bringing those groups together. We provide this neutral platform, where everybody's voice is elevated, and everybody's voice is integrated into that conversation. I think that's just a an incredibly important element of advancing innovation, so that's really what we're striving to be at the middle of and make sure that we're the party that continues to be that integrator of knowledge.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.
